| Mrs Catherine Lebahn Griffin, MCSD CCC-SLP | |
|
209 Taylor Dr, Dillon, MT 59725-7103 | |
| (406) 683-5806 | |
| (406) 683-5806 |
| Full Name | Mrs Catherine Lebahn Griffin |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 34 Years |
| Location | 209 Taylor Dr, Dillon, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558559716 | NPI | - | NPPES |
| 1942364450 | Other | MT | NPI FOR ORGANIZATION |
| 066376 | Other | MT | BLUE CROSS BLUE SHIELD |
| 0533630 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 831 (Montana) | Primary |
| Provider Name | State Of The Heart Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942364450 PECOS PAC ID: 4385781376 Enrollment ID: O20091023000271 |
News Archive
Medicis today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
In 2000, researchers at the UCLA Center for Sleep Research published findings showing that people suffering from narcolepsy, a disorder characterized by uncontrollable periods of deep sleep, had 90 percent fewer neurons containing the neuropeptide hypocretin in their brains than healthy people.
University of Louisville researchers have discovered that a protein previously known for its role in kidney function also plays a significant role in the nervous system. In an article featured in the April 13 issue of the Journal of Neuroscience, they show that the adaptor protein CD2AP is a key player in a type of neural growth known as collateral sprouting.
Calcium antagonists such as nifedipine are used to relieve the symptoms of angina, but there have been doubts about their long-term safety. However, ACTION-A Coronary disease Trial Investigating Outcome with Nifedipine GITS-provides new information on the drug's long-term use. GITS (gastrointestinal therapeutic system) modifies the release of the drug to provide stable long-term concentrations of nifedipine in blood.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Catherine Lebahn Griffin, MCSD CCC-SLP 209 Taylor Dr, Dillon, MT 59725-7103 Ph: (406) 683-5806 | Mrs Catherine Lebahn Griffin, MCSD CCC-SLP 209 Taylor Dr, Dillon, MT 59725-7103 Ph: (406) 683-5806 |
News Archive
Medicis today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
In 2000, researchers at the UCLA Center for Sleep Research published findings showing that people suffering from narcolepsy, a disorder characterized by uncontrollable periods of deep sleep, had 90 percent fewer neurons containing the neuropeptide hypocretin in their brains than healthy people.
University of Louisville researchers have discovered that a protein previously known for its role in kidney function also plays a significant role in the nervous system. In an article featured in the April 13 issue of the Journal of Neuroscience, they show that the adaptor protein CD2AP is a key player in a type of neural growth known as collateral sprouting.
Calcium antagonists such as nifedipine are used to relieve the symptoms of angina, but there have been doubts about their long-term safety. However, ACTION-A Coronary disease Trial Investigating Outcome with Nifedipine GITS-provides new information on the drug's long-term use. GITS (gastrointestinal therapeutic system) modifies the release of the drug to provide stable long-term concentrations of nifedipine in blood.
› Verified 8 days ago
Ms. Carol Ann Uhler, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 653 Barnett Ave, Dillon, MT 59725 Phone: 406-491-1952 | |
Jackie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Oregon St, Dillon, MT 59725 Phone: 270-576-2507 | |
Jolene Marie Snyder, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 209 Taylor Dr, Dillon, MT 59725 Phone: 406-683-5806 | |
Kandis Lee Hoem, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 W Park St, Dillon, MT 59725 Phone: 406-533-8998 | |
Ms. Donna M Black, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Oregon St, Dillon, MT 59725 Phone: 406-683-5105 Fax: 406-683-6388 | |
State Of The Heart Therapy Inc. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 435 S Atlantic St, Suite 102, Dillon, MT 59725 Phone: 406-683-5806 Fax: 406-683-5806 |